Leap Therapeutics Inc. Stock
Leap Therapeutics Inc. took a tumble today and lost -€0.064 (-7.290%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Leap Therapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Leap Therapeutics Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
Show more
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
Show more
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
Show more
Ratings data for LPTX provided by MarketBeat